Press Releases
- Preclinical data of tasquinimod in myelofibrosis to be presented at ASH 2024
- Active Biotech’s clinical trial of tasquinimod in myelofibrosis approved in Europe
- Active Biotech publishes prospectus
- Extraordinary General Meeting of Active Biotech AB
- European Patent Office has granted Active Biotech’s patent application for eye drop formulation of laquinimod